Anavex Life Sciences Corp...
(AVXL)
undefined
undefined%
At close: undefined
8.50
1.07%
After-hours Dec 13, 2024, 07:06 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 |
| Net Income | -47.51M | -47.98M | -37.91M | -26.28M | -26.29M | -17.45M | -13.46M | -14.74M | -12.11M | -11.37M | -3.70M | -8.30M | -7.31M | -8.78M | -5.50M | -5.35M | -1.58M | -25.53K | -91.63K | -14.39K |
| Depreciation & Amortization | - | - | - | - | - | - | - | 1.25K | 995.00 | 768.00 | 576.00 | 1.86K | 1.66K | 910.00 | 410.00 | 220.00 | - | - | - | - |
| Stock-Based Compensation | 16.37M | 18.38M | 8.23M | 4.88M | 6.43M | 5.52M | 4.14M | 5.06M | 1.63M | 637.92K | 1.00M | 302.21K | 1.27M | 770.05K | 812.34K | 1.68M | - | - | - | - |
| Other Working Capital | 1.52M | 6.28M | -1.46M | -349.20K | 617.82K | -646.00K | 382.81K | 152.04M | 1.24M | -336.25K | -510.97K | 10.44K | 845.89K | -504.91K | -181 | - | 463.79K | -220 | - | 2.50K |
| Other Non-Cash Items | 845.00K | 13.35M | 11.77M | 6.62M | 35.38K | 5.61M | -75.20K | -145.57K | 4.53M | 2.84M | 978.10K | 121.48K | -7.34M | 2.98M | 170.16K | 2.42M | 800.00K | 2.38K | 16.00K | - |
| Deferred Income Tax | - | - | - | - | - | - | - | -58.14K | 482.16K | 5.56M | 475.39K | 3.89M | 8.39M | 499.78K | 794.57K | -1.68M | - | - | - | - |
| Change in Working Capital | 2.50M | 5.36M | -706.44K | 116.52K | 1.30M | -646.00K | 382.81K | 640.07K | 1.24M | -336.25K | 465.91K | 2.29M | 1.18M | -60.91K | 927.29K | 460.36K | 454.74K | -9.27K | 14.55K | 2.50K |
| Operating Cash Flow | -27.79M | -24.24M | -30.38M | -21.29M | -18.53M | -12.58M | -9.02M | -9.24M | -4.23M | -2.66M | -777.57K | -1.69M | -3.80M | -4.59M | -2.79M | -2.47M | -325.25K | -32.43K | -61.07K | -11.89K |
| Capital Expenditures | - | - | - | - | - | - | - | - | - | -3.02K | - | - | - | -3.31K | -1.24K | -1.08K | - | - | - | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing Acitivies | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.31K | -1.24K | -1.08K | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | -3.02K | - | - | - | -3.31K | -1.24K | -1.08K | - | - | - | - |
| Debt Repayment | - | - | - | - | - | - | - | - | - | 10.00M | 250.00K | 581.50K | 750.00K | 1.42M | 1.20M | 1.35M | - | 20.00K | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 1.78M | 303.00K | 23.40K | -403.76K | -50.00K | -101.13K | - | 3.13M | -88.14K | -788.71K | 861.28K | -8.15K | -100.00K | - | 300.00K | - | 313.00K | 23.73K | 9.94K | - |
| Financial Cash Flow | 29.65M | 21.29M | 153.24M | 28.35M | 17.78M | 8.07M | 27.27M | 3.13M | 12.26M | 9.58M | 1.11M | 1.57M | 3.67M | 4.51M | 3.14M | 2.48M | 313.00K | 43.73K | 33.94K | 40.00K |
| Net Cash Flow | 1.87M | -2.95M | 122.86M | 7.06M | -745.01K | -4.51M | 18.25M | -6.10M | 8.03M | 6.92M | 333.71K | -123.34K | -129.97K | -86.33K | 344.64K | 6.33K | -12.25K | 11.30K | -27.13K | 28.11K |
| Free Cash Flow | -27.79M | -24.24M | -30.38M | -21.29M | -18.53M | -12.58M | -9.02M | -9.24M | -4.23M | -2.66M | -777.57K | -1.69M | -3.80M | -4.60M | -2.80M | -2.48M | -325.25K | -32.43K | -61.07K | -11.89K |